Blog
News, research and explainers on hyperbaric oxygen therapy — drawn from authoritative medical, government and academic sources.
The Jaw That Refuses to Heal: Hyperbaric Oxygen and a Drug-Made Bone Disease
An 18-patient series from a Portuguese hyperbaric unit reports clinical response in 61 percent of patients with medication-related osteonecrosis of the jaw — and relapse within a median of two months in five of them. Set beside a Cochrane review, a 2026 network meta-analysis and the FDA's cleared-indication list, it shows how a compelling mechanism can outrun its evidence.
Oxygen's Second Face: The Lung at the Dose Limit of Hyperbaric Therapy
Two new mouse studies from a Shanghai naval-medicine group trace how the lung mounts its own defence against hyperbaric oxygen — via a cytochrome P450 pathway that mops up oxidative stress before inflammatory cells tear the alveolar barrier apart. Set beside a dive-table dose audit and two human diving studies, it is a portrait of oxygen as a drug with a ceiling, not a wellness tonic.
Four Patients, One Chamber: A First-in-Human Test of Hyperbaric Oxygen in Septic Shock
A University of Iowa phase I trial gave four patients in septic shock 60 minutes of hyperbaric oxygen at 2.5 ATA. Two showed transient microvascular gains, all four controls declined, cytokines and mitochondrial function did not budge, and nobody was harmed. It is the most honest kind of negative result — and a useful reminder that septic shock is not an approved use of the chamber.
Seven Studies, 502 Older Adults: A New Review Sorts What Hyperbaric Oxygen Can and Cannot Do
A PROSPERO-registered systematic review of hyperbaric oxygen therapy in people aged 51–85 finds genuine but preliminary cognitive gains, mostly modest physical benefits, and mild side effects — against a regulatory reality in which aging and performance sit outside every FDA-cleared indication.
Can a Surfactant Do What the Chamber Does? A Lab-on-a-Chip Test of Gas Embolism Therapy
A McGill and Memorial University team built a microvasculature-mimicking chip to test whether a common surfactant can make gas bubbles less dangerous — an idea its authors frame as an alternative or adjunct to hyperbaric oxygen. The clinical evidence still points to the chamber, and to the clock.
A Backstop for Failing Eyelid and Orbital Grafts — and What an 11-Patient Case Series Can Actually Prove
A retrospective from Turkish eye centres describes 11 high-risk oculoplastic reconstructions supported by adjunctive hyperbaric oxygen. Most avoided further major surgery, but the paradox that 20-session patients healed more slowly is a lesson in how easily case series mislead.
In Carbon Monoxide Poisoning, the Pressure of the First Session May Matter More Than the Number That Follow
A 30-year retrospective from a single regional hyperbaric centre found that patients given 2.8 ATA on their first session developed delayed neuropsychiatric sequelae about half as often as those given 2.0 ATA — while adding two more sessions changed nothing.
The Chamber Applies Pressure. Whether the Tissue Gets Oxygen Is a Separate Question
A French case series used laser speckle imaging to watch wound perfusion shift during hyperbaric sessions, while Dartmouth researchers built chambers that fit inside MRI and EPR scanners. Together they make the case that the dose inside a chamber is far less uniform than the prescription implies.
No Chamber for 24 Hours: Freediving's Improvised Answer to Decompression Sickness
A new case report describes a competitive freediver who surfaced from 117 metres with severe neurological decompression illness and recovered after two emergency recompressions in the sea—a manoeuvre physicians say can bridge to HBOT, but has no freediving-specific guidelines and carries real risk.
Before the Chamber: Why HBOT Can't Rescue a Wound That Was Never Set Up to Heal
A new analysis from NYU Langone's hyperbaric and advanced wound healing center finds the same fixable failures—missing compression, ineffective offloading, unchecked edema—in wounds referred for advanced therapy including HBOT.
Hyperbaric Oxygen and the Declining Brain: A Beijing Review Maps the Mechanisms, Then Names the Gaps
A new narrative review from Xuanwu Hospital and Nantong University argues that Alzheimer's disease, vascular cognitive impairment and traumatic brain injury share a hypoxia-driven failure of the neurovascular unit — and that hyperbaric oxygen can be aimed at it. The same paper concedes the clinical evidence is still exploratory, and cognitive impairment is not an FDA-cleared indication.
The Nurse in the Chamber: Hyperbaric Medicine's Quiet Occupational Hazard
Every multiplace hyperbaric session puts a staff member inside a pressurised steel room breathing air while the patient breathes oxygen. A new Swedish modelling paper rewrites the attendant's oxygen schedule — against an evidence base that includes documented spinal decompression sickness in chamber staff.
The Hyperbaric Chamber Is Also a Chronic-Disease Waiting Room
A Tasmanian hyperbaric department bolted six weeks of lifestyle-medicine education onto its oxygen treatment course. Patients and staff liked it — but the study was 12 people, unblinded, single-centre, and proves nothing about outcomes.
Hyperbaric Oxygen and the Sickle Cell Leg Ulcer: One More Case, Still No Trial
A September 2026 case report from Qatar describes a stubborn sickle cell leg ulcer that closed after nine hyperbaric oxygen sessions. The outcome is encouraging — the evidence base around it remains close to empty, and HBOT is not an FDA-cleared indication for sickle cell disease.
Can Pressurized Oxygen Help or Hurt in Cancer? A New Review Says It Depends
A September 2026 review in Biology concludes that hyperbaric oxygen therapy neither universally accelerates tumors nor works as a standalone cancer treatment — but remains a defensible, FDA-cleared adjunct for radiation injuries.
EEG Entropy Rises in Vegetative-State Patients During Hyperbaric Oxygen Therapy, Study Finds
A retrospective study of 40 patients with prolonged disorders of consciousness finds that quantitative EEG complexity and permutation entropy increase over a 20-session HBOT course, paralleling gains on the Coma Recovery Scale-Revised.
HBOT Improves Motor and Sensory Recovery After Incomplete Spinal Cord Injury, Meta-Analysis Finds
A new systematic review and meta-analysis of 15 randomized controlled trials reports that adjunctive hyperbaric oxygen therapy significantly improves motor function, sensory scores, and daily living independence in patients with traumatic incomplete spinal cord injury.
Stellate Ganglion Block Plus HBOT Shows Promise for Sudden Hearing Loss, Taiwanese Study Finds
New three-arm retrospective study from Taiwan suggests combining stellate ganglion block with hyperbaric oxygen therapy may improve outcomes for sudden sensorineural hearing loss patients.
When Blood Transfusion Isn't Possible: HBOT as a Bridge Therapy for Severe Anemia
Severe anemia is an FDA-cleared indication for hyperbaric oxygen therapy, providing a critical bridge when red blood cell transfusion is impossible due to religious objection, crossmatch incompatibility, or blood unavailability.
HBOT Shows Promise for Spinal Cord Injury Recovery: Florida Study Reveals Antioxidant Mechanism
University of Florida researchers demonstrate hyperbaric oxygen therapy preserves diaphragm function after cervical spinal cord injury through antioxidant upregulation, though FDA has not cleared HBOT for this indication.
HBOT for Severe Traumatic Limb Injuries: New Meta-Analysis Suggests Benefits, But Questions Remain
A 2026 systematic review and meta-analysis finds hyperbaric oxygen therapy may reduce complications and improve outcomes in severe traumatic limb injuries, though FDA clearance is limited to crush injury and compartment syndrome.
HBOT for Bell's Palsy: New Case Series Suggest Promise, But Evidence Remains Limited
Recent case reports and a 2025 case series indicate hyperbaric oxygen therapy may aid recovery from Bell's palsy when steroids fail, though FDA has not cleared HBOT for this indication.
Hyperbaric Oxygen Therapy Restores Vision and Hearing After Selenium Toxicity: A Case Report
A 2026 case report documents dramatic recovery from acute bilateral vision and hearing loss following high-dose selenium ingestion, with HBOT playing a key role in the multidisciplinary treatment approach.
HBOT for Post-Surgical Pyoderma Gangrenosum: Brazilian Case Series Reports Excellent Response
A 2026 case series from Indian Journal of Plastic Surgery documents multidisciplinary management of post-surgical pyoderma gangrenosum following cosmetic procedures, with hyperbaric oxygen therapy showing excellent clinical response in 6 of 10 patients.
Cerebral Air Gas Embolism After CT-Guided Lung Biopsy: Emergency HBOT Saves Lives
New 2026 case report documents emergency management of cerebral air gas embolism—a rare but fatal complication of CT-guided lung biopsy—highlighting HBOT as definitive FDA-cleared treatment.
Retinal Artery Occlusion Patients Face Elevated Heart and Stroke Risk; HBOT Role in Visual Outcomes Examined
New 2026 study in Retina journal tracks major adverse cardiovascular and cerebrovascular events after retinal artery occlusion, highlighting systemic risks and HBOT's association with visual recovery.
Bronchial Chondronecrosis After Proton Therapy: HBOT Saves Patient's Airway
A case report from Japan documents successful hyperbaric oxygen therapy for severe bronchial cartilage damage following proton beam radiotherapy, highlighting HBOT's role in treating radiation-induced tissue injuries.
FDA Recommends UHMS-Accredited Facilities for Hyperbaric Oxygen Therapy
The FDA now explicitly advises patients to seek hyperbaric oxygen therapy only at hospitals and facilities accredited by the Undersea and Hyperbaric Medical Society, reinforcing safety standards amid growing concerns about unregulated operators.
Hyperbaric Oxygen Therapy for Radiation Cystitis: A 2026 Evidence Review
New review in Current Urology Reports examines HBOT's role in managing radiation-induced bladder injury, an FDA-cleared indication with expanding clinical applications.
HBOT for Traumatic Brain Injury: New Meta-Analysis Reopens a Contested Question
A comprehensive August 2026 systematic review and meta-analysis in Complementary Therapies in Medicine finds HBOT may improve functional outcomes in TBI patients—reigniting debate amid conflicting VA/DoD trial results.
HBOT for Musculoskeletal Conditions: New Systematic Review Sifts Evidence from Aspiration
A comprehensive August 2026 systematic review in BMC Musculoskeletal Disorders examines HBOT's efficacy across muscle, tendon, ligament, and bone conditions—finding promise for avascular necrosis but limited evidence for sports recovery.
Hyperbaric Oxygen in Plastic Surgery: First Specialty-Wide Systematic Review Finds Promise — and a Thin Evidence Base
A UCLA systematic review in Plastic and Reconstructive Surgery Global Open pools 18 studies and 1,281 patients on HBOT in reconstructive surgery — finding encouraging salvage rates for flaps, grafts and threatened limbs, but evidence dominated by case series and a meta-analysis that fell short of statistical significance.
Oxygen Under Pressure Against a Flesh-Eating Infection: A New Review Sifts the HBOT Evidence for Necrotizing Fasciitis
A 2026 narrative review in Frontiers in Cellular and Infection Microbiology maps what is known — and still unproven — about adjunctive hyperbaric oxygen therapy for necrotizing soft tissue infections, where mortality has been stuck at 20 to 40 percent for decades.
How Much Pressure Does the Brain Need? New Rat Study Maps HBOT's Dose-Response for Memory and Plasticity
A study published August 2 in Neuroscience tested hyperbaric oxygen at 1.6, 2.0 and 2.4 ATA in healthy rats and found a distinct pressure sweet spot for hippocampal plasticity and recognition memory — a preclinical finding with direct relevance to the pressure debate in the wellness chamber market.
Wheeling a Ventilated ICU Patient Into a Hyperbaric Chamber: A Staff Survey Maps the Steps That Get Missed
A pilot survey at Poland's National Centre for Hyperbaric Medicine asked nurses and physicians which peri-procedural tasks they had seen skipped when critically ill, mechanically ventilated patients undergo HBOT. The answers informed the first dedicated peri-HBOT safety checklist prototype.
Aurelius Clinic Treats 60 Veterans with HBOT: Inside the Pennsylvania Program Drawing TBI and PTSD Patients from 25 States
Non-profit Aurelius Clinic at Harrisburg University has treated over 60 veterans and special operators using a 19-day accelerated HBOT protocol. The program combines hyperbaric oxygen with transcranial magnetic stimulation and physical training—but FDA has not cleared HBOT for TBI or PTSD.
HBOT for Osteonecrosis of the Femoral Head: New Network Meta-Analysis Ranks Joint-Preserving Therapies
A July 2026 network meta-analysis in Frontiers in Cell and Developmental Biology compares HBOT against core decompression, cell therapy, and shock wave therapy for early-stage hip osteonecrosis.
HBOT Shows Promise for Postoperative Macular Edema Recovery, But FDA Approval Remains Elusive
A new 2026 case study demonstrates accelerated recovery from postoperative macular edema with hyperbaric oxygen therapy, highlighting both the therapeutic potential and regulatory limitations in ophthalmologic applications.
HBOT for Autism: New 2025 Meta-Analysis Shows Promise as FDA Removes Warning Page
A comprehensive 2025 meta-analysis of 17 studies suggests hyperbaric oxygen therapy may improve core autism symptoms, coinciding with FDA's removal of its 'potentially dangerous' warning page for autism treatments.
Korean Study: HBOT Shows Promise for Long COVID Fatigue and Brain Fog
A prospective observational study from South Korea finds that 73% of Long COVID patients recovered from fatigue after 10 sessions of hyperbaric oxygen therapy, with measurable improvements in verbal and working memory.
The HOBIT Trial: Inside the NIH-Funded Study That Could Change Severe Brain Injury Treatment
A landmark NIH-funded trial testing hyperbaric oxygen for severe traumatic brain injury is nearing completion. With 160 of 200 patients enrolled, researchers are closer than ever to answering whether pressurized oxygen can improve outcomes for the most devastating brain injuries.
FDA Issues Urgent Safety Letter on HBOT Devices After Reports of Fires, Injuries, and Deaths
The FDA's August 2025 letter to health care providers warns of serious injuries and deaths linked to hyperbaric oxygen therapy devices, emphasizing fire risks, proper training, and strict adherence to manufacturer protocols.
Buying a Hyperbaric Chamber for Home Use: A Clinician's Checklist
Home hyperbaric chambers have moved from fringe to mainstream. A practical, safety-first checklist for evaluating pressure ratings, certifications, oxygen handling, installation, and vendor support before buying a chamber for your home.
Hard-Shell vs Soft-Shell Hyperbaric Chambers: A Clinical Perspective
The hard-shell vs soft-shell decision is really a pressure decision. What the clinical literature's 2.0 ATA protocols mean for chamber choice, where mild 1.3–1.5 ATA systems genuinely fit, and how to match the machine to the use case.
How Much Does a Hyperbaric Chamber Cost? What Clinics Actually Pay
Hyperbaric chamber prices span $5,000 to over $800,000 depending on pressure rating, shell construction, and capacity. A practical breakdown of what clinics and home buyers actually pay — and the ownership costs the sticker price hides.
HBOT for Filler-Induced Vascular Occlusion: What the Evidence Actually Shows
A 2026 scoping review mapped every published report of hyperbaric oxygen used for dermal filler vascular occlusion and found only case-level evidence. HBOT is off-label here — not FDA-cleared, not a UHMS indication, and never a substitute for hyaluronidase.
Hyperbaric Oxygen Shows Early Promise in Drug-Refractory Ulcerative Colitis
A Dutch phase 2a pilot found adjunctive hyperbaric oxygen therapy improved clinical and endoscopic outcomes in ulcerative colitis that had failed multiple drugs. The trial was small and unblinded, and HBOT is not FDA-cleared for colitis.
Gas Gangrene and HBOT: How Hyperbaric Oxygen Saves Lives in Clostridial Myonecrosis
Gas gangrene is a surgical emergency with mortality rates exceeding 25% without proper treatment. Hyperbaric oxygen therapy is FDA-cleared and UHMS-recommended as part of the standard triple therapy for this devastating infection.
HBOT for Crush Injury and Compartment Syndrome: An Underused FDA-Cleared Lifesaver
Crush injury and compartment syndrome are time-critical emergencies where hyperbaric oxygen therapy is FDA-cleared. New research explores optimal timing, pressure protocols, and outcomes in acute traumatic ischemia.
HBOT for Diabetic Foot Ulcers: What GRADE Evidence Says in 2026
New 2026 reviews apply GRADE methodology to hyperbaric oxygen therapy for diabetic foot ulcers, finding moderate-certainty evidence for healing benefits while highlighting gaps in long-term data and patient selection.
HBOT for Compromised Skin Grafts and Flaps: How Oxygen Pressure Saves Surgical Outcomes
New 2026 evidence confirms hyperbaric oxygen therapy improves graft survival rates when vascular compromise threatens reconstructive surgery outcomes.
Hyperbaric Oxygen Plus Polarized Light Therapy Shows Promise for Neuropathic Foot Ulcers: New RCT
A randomized controlled trial from Egypt demonstrates that combining hyperbaric oxygen therapy with polarized light therapy significantly improves healing in neuropathic foot ulcers compared to standard care alone.
Cardiac Extracellular Vesicle Proteomics Reveals How HBOT Reverses Carbon Monoxide–Induced Heart Damage
A new Taiwanese study uses cardiac extracellular vesicle proteomics to uncover the molecular mechanisms by which hyperbaric oxygen therapy protects the heart after carbon monoxide poisoning.
HBOT vs. Mild HBOT: Why Pressure and Oxygen Levels Matter
A new 2026 narrative review clarifies the critical differences between clinical hyperbaric oxygen therapy and mild hyperbaric oxygen therapy—differences that wellness marketing often obscures.
HBOT Speeds Recovery from Exercise-Induced Muscle Injury, Meta-Analysis Finds
A 2026 systematic review and meta-analysis of 10 RCTs shows hyperbaric oxygen therapy significantly accelerates recovery from exercise-induced muscle injury, though effects on muscle soreness are mixed.
Community-Delivered HBOT for Long COVID: A 2026 Pilot Study Shows Promise
A new UK pilot study finds community-based hyperbaric oxygen therapy improved fatigue, breathlessness, and quality of life in Long COVID patients—while highlighting the need for larger controlled trials.
When Bone Infections Refuse to Heal: HBOT as an FDA-Cleared Lifeline
Chronic refractory osteomyelitis affects over 50,000 Americans annually. Learn why HBOT is an FDA-cleared adjunctive therapy and what the evidence shows about cure rates, mechanisms, and long-term outcomes.
When Spine Surgery Causes Blindness: A 2026 Case Report on HBOT for Perioperative Vision Loss
A rare but devastating complication of prone spinal surgery—central retinal artery occlusion—left a patient with hand-motion vision. Delayed hyperbaric oxygen therapy restored functional sight, illustrating both the risks of positioning and the therapeutic window for this FDA-cleared indication.
HBOT for Thermal Burns: What a New 2026 Systematic Review Reveals
A comprehensive 2026 systematic review examines hyperbaric oxygen therapy as an adjunct for thermal burn care, finding promise for reduced surgeries and faster healing while highlighting key evidence gaps.
What Can Go Wrong: A Clinical Guide to HBOT Side Effects
A new 2026 UHMS Journal review quantifies the risks of hyperbaric oxygen therapy—from barotrauma to oxygen toxicity—and explains how proper protocols keep complications rare.
Hyperbaric Oxygen Therapy for Radiation-Induced Brain Necrosis: New Review Shows 60% Response Rate
A June 2026 Frontiers in Oncology review synthesizes evidence on HBOT for radiation necrosis, reporting symptom stabilization or improvement in approximately 60% of patients.
Hyperbaric Oxygen Therapy Shows Promise for Treatment-Refractory Colitis in Early Trial
A phase 2a pilot study from the Netherlands suggests HBOT may help stabilize biologic-refractory ulcerative colitis, offering a potential new avenue when standard therapies fail.
The HBOT Boom in Med Spas and Celebrity Homes Has Safety Experts Warning of 'Absolute Anarchy'
As hyperbaric oxygen therapy explodes in popularity at med spas and private residences, safety experts warn of unregulated expansion, fire risks, and a tragic Michigan chamber explosion that killed a 5-year-old boy.
Can Hyperbaric Oxygen Therapy Ease Fibromyalgia Pain? Evidence and FDA Reality
Patients with fibromyalgia report reduced pain after HBOT, but the FDA has not cleared the therapy for this use. A look at the emerging research and the regulatory caution that surrounds it.
Neurological and Cardiac Determinants Drive HBOT Selection in Carbon Monoxide Poisoning: New 2026 Study
A retrospective study of 272 patients reveals that neurological impairment and cardiac involvement—not just carboxyhemoglobin levels—are the primary factors guiding hyperbaric oxygen therapy decisions in carbon monoxide poisoning.
Hyperbaric Oxygen Therapy Shows Promise for Post-Stroke Depression in New Randomized Trial
A 2026 sham-controlled study reports significant reductions in depression scores among stroke survivors treated with HBOT, alongside biomarker changes suggesting neuroplasticity. Here's what the evidence shows—and why FDA clearance remains distant.
Hyperbaric Oxygen for Long COVID: Promising Israeli Results Meet Skeptical Swedish Data
Two recent randomized trials paint different pictures of HBOT for long COVID. We break down the Shamir Medical Center study showing lasting cognitive gains versus the Swedish HOT-LoCO trial that found no benefit over sham—and what the FDA says about off-label use.
New Mouse Study Suggests HBOT May Slow Alzheimer's Pathology — But FDA Has Not Approved It
A February 2026 study in Experimental Neurology shows hyperbaric oxygen reduced amyloid plaques and improved cognition in Alzheimer's mice. Human trials show promise, yet the FDA maintains HBOT is not approved for dementia treatment.
When Silence Strikes Suddenly: How HBOT Became a Lifeline for Sudden Hearing Loss
Idiopathic sudden sensorineural hearing loss is one of the few neurological emergencies where hyperbaric oxygen therapy holds FDA clearance. A look at the evidence, treatment windows, and why timing matters.
Do Hyperbaric Chambers Actually Help Athletes Recover? A 2025 Evidence Review
A new narrative review in the Undersea and Hyperbaric Medicine Journal examines the evidence for HBOT in athletic recovery—finding promise for soft-tissue injuries but limited data for performance enhancement.
HBOT Shows Promise for ME/CFS Symptoms in New German Study—With a Caveat
A prospective cohort study from Berlin's Charité hospital finds hyperbaric oxygen therapy improved physical function and modulated thalamic connectivity in ME/CFS patients, but FDA clearance for this indication remains absent.
NHS England to Slash Hyperbaric Chamber Network: A Looming Access Crisis
NHS England plans to cut hyperbaric oxygen therapy centers from eight to three, raising alarms about emergency access for divers and patients with approved indications.
FDA Reiterates Warning on Unproven Hyperbaric Oxygen Uses as Clinical Research Expands
Federal regulators caution that most wellness and longevity claims for hyperbaric oxygen therapy remain uncleared, even as new trials probe its role in brain injury and chronic wounds.
HBOT for Veterans: What the VA, Pentagon, and GAO Actually Concluded About TBI and PTSD
Hyperbaric oxygen is heavily marketed to veterans for brain injury and PTSD. The federal research record — large sham-controlled trials, the VA/DoD guideline, and a GAO review — tells a far more cautious story.
Hyperbaric Oxygen for Diabetic Foot Ulcers: What Cochrane and Medicare Actually Say
The highest-quality evidence review and U.S. payer policy agree on a cautious middle ground: a real short-term healing benefit that fades by one year, built on weak trials — and Medicare coverage tightly gated to advanced wounds that have failed standard care.
Inside the HBOT Research Frontier: Long COVID, Brain Injury, and What the Trials Actually Show
Hyperbaric oxygen is moving from anecdote toward evidence on its hardest targets — the post-COVID brain and traumatic brain injury. A sham-controlled trial reported real cognitive gains, and large new randomized studies are now enrolling.
Can HBOT Turn Back the Clock? The Telomere Studies, and Where the FDA Draws the Line
Hyperbaric oxygen is increasingly sold as a longevity 'biohack.' Real peer-reviewed studies report longer telomeres and better cognition in older adults — but the FDA has never cleared it for aging, and a 2025 safety letter followed fatal chamber fires.